Your Watchlists

Customize MarketWatch

Have Watchlists? Log in to see them here or sign up to get started.

Symbol

Company

Price

Chg/Chg %
No Items in Watchlist

There are currently no items in this Watchlist.

No Saved Watchlists

Create a list of the investments you want to track.

Uh oh

Something went wrong while loading Watchlist.

Recently Viewed Tickers

No Recent Tickers

Visit a quote page and your recently viewed tickers will be displayed here.

SAVA Overview

Key Data

  • Open $52.93
  • Day Range 50.63 - 56.95
  • 52 Week Range 2.78 - 146.16
  • Market Cap $2.33B
  • Shares Outstanding 40.01M
  • Public Float 37.31M
  • Beta 1.08
  • Rev. per Employee N/A
  • P/E Ratio N/A
  • EPS -$0.37
  • Yield N/A
  • Dividend N/A
  • Ex-Dividend Date N/A
  • Short Interest 5.4M 08/13/21
  • % of Float Shorted 14.48%
  • Average Volume 5.88M

Performance

5 Day
  • -54.80%
1 Month
  • -37.24%
3 Month
  • -6.66%
YTD
  • 680.94%
1 Year
  • 1,629.22%

Analyst Ratings

Recent News

  • MarketWatch
  • Dow Jones

Cassava Sciences stock bounces 4.5% premarket, after plunging 31.4% on Wednesday

Aug. 26, 2021 at 8:44 a.m. ET by Tomi Kilgore

Cassava Sciences stock price target raised to $145 from $111 at B. Riley

Aug. 3, 2021 at 7:58 a.m. ET by Tomi Kilgore

Cassave Sciences stock price target raised to $190 from $80 at Maxim Group

Jul. 7, 2021 at 8:30 a.m. ET by Tomi Kilgore

Cassava Sciences started at buy with $78 stock price target at B. Riley

Apr. 27, 2021 at 7:35 a.m. ET by Tomi Kilgore

Cassava Sciences stock price target raised to $80 from $14 at Maxim Group

Feb. 16, 2021 at 7:53 a.m. ET by Tomi Kilgore

Cassava Sciences to offer $200 mln of shares priced at $49 each vs. $50.29 at Tuesdays close

Feb. 10, 2021 at 6:32 a.m. ET by Ciara Linnane

  • Other News
  • Press Releases

Cassava Sciences Inc.

Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier and Barry M. Sherman in May 1998 and is headquartered in Austin, TX.